GOVX GeoVax Labs Inc

Price (delayed)

$1.82

Market cap

$6.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$17.42

Enterprise value

$5.44M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On ...

Highlights
The EPS has soared by 81% year-on-year and by 22% since the previous quarter
The debt has dropped by 53% since the previous quarter
The equity has dropped by 94% year-on-year and by 87% since the previous quarter
The quick ratio has plunged by 82% YoY and by 65% from the previous quarter

Key stats

What are the main financial stats of GOVX

GOVX stock price

How has the GeoVax Labs stock price performed over time
Intraday
-10.34%
1 week
-24.17%
1 month
43.31%
1 year
-93.5%
YTD
-57.48%
QTD
31.88%

Financial performance

How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.36M
Net income
-$21.37M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 26% YoY and by 7% from the previous quarter
GeoVax Labs's net income has increased by 13% YoY

Price vs fundamentals

How does GOVX's price correlate with its fundamentals

Growth

What is GeoVax Labs's growth rate over time

Valuation

What is GeoVax Labs stock price valuation
P/E
N/A
P/B
7.13
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 81% year-on-year and by 22% since the previous quarter
The P/B is 115% more than the last 4 quarters average of 3.7 and 26% more than the 5-year quarterly average of 6.3
The equity has dropped by 94% year-on-year and by 87% since the previous quarter

Efficiency

How efficient is GeoVax Labs business performance
The return on equity has dropped by 61% since the previous quarter and by 39% year-on-year
GOVX's return on invested capital is down by 40% since the previous quarter
The ROA has declined by 39% year-on-year and by 36% since the previous quarter

Dividends

What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOVX.

Financial health

How did GeoVax Labs financials performed over time
GOVX's total assets is 20% more than its total liabilities
The quick ratio has plunged by 82% YoY and by 65% from the previous quarter
GOVX's total assets has plunged by 72% YoY and by 53% from the previous quarter
The debt is 20% smaller than the equity
The equity has dropped by 94% year-on-year and by 87% since the previous quarter
The debt has dropped by 53% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.